GLOBE excision-logo-2019-mark-1c (1).png
Excision BioTherapeutics Presents Data to Support HIV Cure Using CRISPR Gene Editing Technology
November 21, 2019 12:00 ET | Excision BioTherapeutics
Oakland, CA, Nov. 21, 2019 (GLOBE NEWSWIRE) -- On November 20 at the 6th Annual Personalized Nanomedicine Symposium, researchers working with Excision BioTherapeutics, a gene therapy company...
Excision logo 2.png
CRISPR Gene Editing Eliminates Herpes Simplex Virus and JC Virus, Demonstrating Feasibility of a Potential Functional Cure
November 18, 2019 12:00 ET | Excision BioTherapeutics
Oakland, CA, Nov. 18, 2019 (GLOBE NEWSWIRE) -- At the 2019 International Symposium on Neurovirology, Excision BioTherapeutics, a gene therapy company focusing on curing viral infectious diseases,...
Precision BioSciences Reports Third Quarter 2019 Financial Results and Highlights Ongoing Operational Progress Including Initial Data from PBCAR0191 Phase 1/2a Clinical Trial
November 12, 2019 07:15 ET | Precision Biosciences
DURHAM, N.C., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its...
Logo FINAL.png
Emendo Biotherapeutics Achieves Milestone of Collaboration with Takeda for its OMNI Nuclease Program
August 20, 2019 09:00 ET | Emendo Biotherapeutics
NEW YORK, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Emendo Biotherapeutics today announced that the company achieved the first milestone as laid out in the agreements with Takeda Pharmaceutical Company...
Aldevron Names Michelle Berg President of GMP Business Unit
May 21, 2019 07:30 ET | Aldevron
Fargo, North Dakota, May 21, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leader in the production of plasmid DNA, proteins, mRNA and antibodies, has expanded its leadership team by appointing Michelle Berg...
Amfora Logo.jpg
Amfora Licenses Gene Editing Technology
April 02, 2019 11:15 ET | Amfora Inc
SAN FRANCISCO, April 02, 2019 (GLOBE NEWSWIRE) -- Today Amfora, a biotechnology company, announced it has reached a non-exclusive research and commercial license agreement with Corteva Agriscience™,...
Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease
March 12, 2019 08:05 ET | Aldevron
FARGO, ND, March 12, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease...
Opportunities Outweigh Challenges: Crop Gene Editing and the Food System
February 13, 2019 13:15 ET | CoBank
DENVER, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Investments in gene editing tools for agricultural crops have heated up in recent years and will only intensify in 2019. The technology is increasingly...
Amfora Logo.jpg
United Soybean Board Awards Grant to Amfora to Increase the Protein Content of U.S. Soy
January 03, 2019 08:15 ET | Amfora Inc
SAN FRANCISCO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Amfora, a biotechnology company that is applying gene editing to sustainably feed the planet, announced that it has received a grant from the United...
Gene Modification Therapy Market to See 49.9% Annual Growth Through 2023
September 18, 2018 06:00 ET | BCC Research
WELLESLEY, Mass., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Recent advancements in genetic modification, including better delivery systems, more efficient and durable gene expression constructs, and...